DOWN SYNDROME (DS)
Clinical trials for DOWN SYNDROME (DS) explained in plain language.
Never miss a new study
Get alerted when new DOWN SYNDROME (DS) trials appear
Sign up with your email to follow new studies for DOWN SYNDROME (DS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Vitamin-Like pill protect the brains of people with down syndrome?
Disease control Not yet recruitingThis early-stage trial tests a supplement called MIB-626 (a form of NMN) in 24 adults with Down syndrome. The goal is to see if it is safe and can raise NAD+ levels, which may help protect against Alzheimer's disease. Participants take the pill or a placebo for 28 days and are mo…
Matched conditions: DOWN SYNDROME (DS)
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a drug clear Alzheimer's plaques in people with down syndrome?
Disease control Not yet recruitingThis study tests whether donanemab, given as an IV infusion every 4 weeks, can safely lower amyloid plaques in the brains of 60 adults aged 35–50 with Down syndrome. Participants receive either donanemab or a placebo for 12 months, followed by a 12-month extension where everyone …
Matched conditions: DOWN SYNDROME (DS)
Phase: PHASE4 • Sponsor: Michael Rafii, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC